Mejia-Chew Carlos, Yaeger Lauren, Montes Kevin, Bailey Thomas C, Olsen Margaret A
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Bernard Becker Medical Library, Washington University in St. Louis, St. Louis, Missouri, USA.
Open Forum Infect Dis. 2021 May 20;8(5):ofab035. doi: 10.1093/ofid/ofab035. eCollection 2021 May.
Health care administrative database research frequently uses standard medical codes to identify diagnoses or procedures. The aim of this review was to establish the diagnostic accuracy of codes used in administrative data research to identify nontuberculous mycobacterial (NTM) disease, including lung disease (NTMLD).
We searched Ovid Medline, Embase, Scopus, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov from inception to April 2019. We included studies assessing the diagnostic accuracy of (ICD-9-CM) diagnosis codes to identify NTM disease and NTMLD. Studies were independently assessed by 2 researchers, and the Quality Assessment of Diagnostic Accuracy Studies 2 tool was used to assess bias and quality.
We identified 5549 unique citations. Of the 96 full-text articles reviewed, 7 eligible studies of moderate quality (3730 participants) were included in our review. The diagnostic accuracy of ICD-9-CM diagnosis codes to identify NTM disease varied widely across studies, with positive predictive values ranging from 38.2% to 100% and sensitivity ranging from 21% to 93%. For NTMLD, 4 studies reported diagnostic accuracy, with positive predictive values ranging from 57% to 64.6% and sensitivity ranging from 21% to 26.9%.
Diagnostic accuracy measures of codes used in health care administrative data to identify patients with NTM varied across studies. Overall the positive predictive value of ICD-9-CM diagnosis codes alone is good, but the sensitivity is low; this method is likely to underestimate case numbers, reflecting the current limitations of coding systems to capture NTM diagnoses.
医疗保健管理数据库研究经常使用标准医学代码来识别诊断或程序。本综述的目的是确定管理数据研究中用于识别非结核分枝杆菌(NTM)疾病(包括肺病(NTMLD))的代码的诊断准确性。
我们检索了从创刊到2019年4月的Ovid Medline、Embase、Scopus、Cochrane系统评价数据库、Cochrane对照试验中央注册库和ClinicalTrials.gov。我们纳入了评估国际疾病分类第九版临床修订本(ICD-9-CM)诊断代码识别NTM疾病和NTMLD的诊断准确性的研究。研究由两名研究人员独立评估,并使用诊断准确性研究质量评估2工具来评估偏倚和质量。
我们识别出5549条独特的引文。在审查的96篇全文文章中,我们的综述纳入了7项质量中等的合格研究(3730名参与者)。ICD-9-CM诊断代码识别NTM疾病的诊断准确性在不同研究中差异很大,阳性预测值范围为38.2%至100%,敏感性范围为21%至93%。对于NTMLD,4项研究报告了诊断准确性,阳性预测值范围为57%至64.6%,敏感性范围为21%至26.9%。
医疗保健管理数据中用于识别NTM患者的代码的诊断准确性测量在不同研究中有所不同。总体而言,仅ICD-9-CM诊断代码的阳性预测值良好,但敏感性较低;这种方法可能会低估病例数,反映出编码系统目前在捕捉NTM诊断方面的局限性。